Dr. Fenghe Qiu, Boehringer Ingelheim Pharmaceuticals Inc - Qepler Summits And Conferences

Dr. Fenghe Qiu

Senior Research Fellow
Boehringer Ingelheim Pharmaceuticals Inc
Danbury, USA
At Boehringer Ingelheim we are driven by the desire to serve mankind by improving human and animal health. As a successful, family owned company we p

Fenghe received his Ph.D. in Physical Chemistry from Chinese Academy of Sciences and a BS degree in Chemistry from Shandong University, China.

He has been with Boehringer Ingelheim Pharmaceuticals Inc. for 16 years and currently is a Senior Research Fellow in the department of Material and Analytical Sciences.

His primary responsibility involves analytical development of small molecule entities which includes providing leadership in impurity elucidation and mutagenic impurity risk assessment and control.

He is the current organizer of the GTI Advisory Council within the company.

Prior to BI, Fenghe had several academic assignments including, Mass Spectrometry Lab Manager, Department of Chemistry, Northwestern University; Associate Professor, National Center of Biomedical Analysis of China.

Related Sessions:

Genotoxic Impurities in
Pharmaceuticals Summit 2019

GTI strategies & new methodologies: analysis, in silico & regulations. Challenges & opportunities.
  • 11 Apr 2019
  • Berlin, DE
  • Pharma
Day 2: Friday, 12 April 2019
CASE STUDY: To Be Announced.
View Details